Idiopathic thrombocytopenic purpura surgery: Difference between revisions
Created page with "__NOTOC__ {{ITP}} {{CMG}} ==Overview== ==Surgery== Splenectomy is safe and effective in ~80% of patients with refractory HIV-related thrombocytopenia and treated with ..." |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Surgery== | ==Surgery== | ||
===Splenectomy=== | |||
Splenectomy offers a 2nd line treatment for those who fail steroids. The criteria for surgery are severe thrombocytopenia (<10,000), high risk of bleeding or the requirement of frequent steroids/IVIgG/anti-D treatment to maintain an adequate platelet count. Of the ~15% of children with persistent thrombocytopenia bleeding symptoms are uncommon and splenectomy is rarely required. However splenectomy is an effective treatment option for children with severe / symptomatic thrombocytopenia with a CR of ~75%. Because of the risk for overwhelming sepsis after splenectomy it should be deferred until after 5 years of age. Remember to give immunizations before splenectomy and perioperative antibiotics. Response to IV-IgG often predicts a response to splenectomy (increasing the platelet count to >50,000 with IgG means a >90% RR to splenectomy). | |||
[[Splenectomy]] is safe and effective in ~80% of patients with refractory HIV-related [[thrombocytopenia]] and treated with [[interferon]] (IFN) may be effective in refractory cases of patients coinfected with HCV. A decrease in platelets in HIV can arise secondary to both HCV and hepatitis B (HBV). | [[Splenectomy]] is safe and effective in ~80% of patients with refractory HIV-related [[thrombocytopenia]] and treated with [[interferon]] (IFN) may be effective in refractory cases of patients coinfected with HCV. A decrease in platelets in HIV can arise secondary to both HCV and hepatitis B (HBV). | ||
==References== | ==References== | ||
Revision as of 15:25, 21 September 2012
|
Idiopathic thrombocytopenic purpura Microchapters |
|
Differentiating Idiopathic thrombocytopenic purpura from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Idiopathic thrombocytopenic purpura surgery On the Web |
|
American Roentgen Ray Society Images of Idiopathic thrombocytopenic purpura surgery |
|
Directions to Hospitals Treating Idiopathic thrombocytopenic purpura |
|
Risk calculators and risk factors for Idiopathic thrombocytopenic purpura surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Surgery
Splenectomy
Splenectomy offers a 2nd line treatment for those who fail steroids. The criteria for surgery are severe thrombocytopenia (<10,000), high risk of bleeding or the requirement of frequent steroids/IVIgG/anti-D treatment to maintain an adequate platelet count. Of the ~15% of children with persistent thrombocytopenia bleeding symptoms are uncommon and splenectomy is rarely required. However splenectomy is an effective treatment option for children with severe / symptomatic thrombocytopenia with a CR of ~75%. Because of the risk for overwhelming sepsis after splenectomy it should be deferred until after 5 years of age. Remember to give immunizations before splenectomy and perioperative antibiotics. Response to IV-IgG often predicts a response to splenectomy (increasing the platelet count to >50,000 with IgG means a >90% RR to splenectomy).
Splenectomy is safe and effective in ~80% of patients with refractory HIV-related thrombocytopenia and treated with interferon (IFN) may be effective in refractory cases of patients coinfected with HCV. A decrease in platelets in HIV can arise secondary to both HCV and hepatitis B (HBV).